Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.

Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.

Item
http://www.wikidata.org/entity/Q36047572
Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans.Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin.Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.Neurotensin and its receptors in the control of glucose homeostasis.Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons.The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.Effects of alcohol abstinence on glucose metabolism in Japanese men with elevated fasting glucose: A pilot study.Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgeryXenin-25[Lys13PAL]: a novel long-acting acylated analogue of xenin-25 with promising antidiabetic potential.Stimulation of the endogenous incretin glucose-dependent insulinotropic peptide by enteral dextrose improves glucose homeostasis and inflammation in murine endotoxemia.Appetite-regulating hormones from the upper gut: disrupted control of xenin and ghrelin in night workers.Evaluation of serum xenin and ghrelin levels and their relationship with nonalcoholic fatty liver disease and insulin resistance in obese adolescents.Xenin is a novel anorexigen in goldfish (Carassius auratus).Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.
P2860

Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.

Item
http://www.wikidata.org/entity/Q36047572
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Xenin-25 amplifies GIP-mediate ...... rance but not type 2 diabetes.
@ast
Xenin-25 amplifies GIP-mediate ...... rance but not type 2 diabetes.
@en
type
label
Xenin-25 amplifies GIP-mediate ...... rance but not type 2 diabetes.
@ast
Xenin-25 amplifies GIP-mediate ...... rance but not type 2 diabetes.
@en
prefLabel
Xenin-25 amplifies GIP-mediate ...... rance but not type 2 diabetes.
@ast
Xenin-25 amplifies GIP-mediate ...... rance but not type 2 diabetes.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Xenin-25 amplifies GIP-mediate ...... erance but not type 2 diabetes
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932